Teichmann Sarah A. sold TXG
August 13, 2026 · Form 4 insider transaction
Teichmann Sarah A. sold 5,278 shares of 10x Genomics, Inc. at $57.29 per share, a transaction worth $302.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,278
Price
$57.29
Total value
$302.4K
InsiderTeichmann Sarah A.
RoleDirector
Company10x Genomics, Inc. (TXG)
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateAugust 13, 2026
Filing dateAugust 17, 2026
Shares owned after30,331
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 14, 2026.